Nasal sprays are available by prescription or over the counter (OTC). Most products come in a hand-operated pump bottle or squeeze bottle. Knowing how to use a nasal spray is important, as doing it ...

It has been found highly effective in reducing nasal symptoms in children ≥2 years, adolescents, and adults. It is available as an aqueous suspension of micronized FF in a nasal spray for topical ...

The results? A nasal spray of oxytocin significantly reduced acute feelings of loneliness in participants, especially during group therapy sessions, even months after treatment. In the study ...

Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression ... using one antidepressant medication, and 50% have no response with just one drug.

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...

A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression. The drug made by Johnson & Johnson under the brand name Spravato passed final ...

A doctor may prescribe ketorolac (Toradol), an NSAID available as a nasal spray, to help manage migraine attacks that cause severe pain. They may also recommend ketorolac as a rescue medication if ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment ... using one antidepressant medication, and 50% have no response with just one drug.

Wed, January 22, 2025 at 1:29 PM UTC I’m An ER Doctor. When I Became A Patient For The First Time, I Was Shocked By What I Experienced. The cofounder of Huel says our diets are bad for our ...

Now, the Food and Drug Administration (FDA) has expanded approval for Johnson & Johnson's nasal spray, Spravato, to be used as a standalone treatment for people with severe depression who haven't ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

Johnson & Johnson has announced that the U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray as the first and only monotherapy for adults with major depressive ...